Jiang_2020_Eur.J.Pharmacol_868_172874

Reference

Title : Inhibition of soluble epoxide hydrolase attenuates airway remodeling in a chronic asthma model - Jiang_2020_Eur.J.Pharmacol_868_172874
Author(s) : Jiang JX , Guan Y , Shen HJ , Jia YL , Shen J , Zhang LH , Liu Q , Zhu YL , Xie QM
Ref : European Journal of Pharmacology , 868 :172874 , 2020
Abstract :

Airway remodeling in asthma is difficult to treat because of its complex pathophysiology that involves proinflammatory cytokines, as well as the arachidonic acid cytochrome P-450 (CYP) pathway; however, it has received little attention. In this study, we assessed the efficacy of a soluble epoxide hydrolase (sEH) on airway remodeling in a mouse model of chronic asthma. The expression of sEH and CYP2J2 and the level of 14,15-epoxyeicosatrienoic acid (14,15-EET), airway remodeling and hyperresponsiveness (AHR) were analyzed to determine the level of sEH inhibition. AUDA, a sEH inhibitor, was given daily for 9 weeks orally, which significantly increased the level of 14,15-EET by inhibiting the expression of sEH and increasing the expression of CYP2J2 in lung tissues. The inhibition of sEH reduced the expression of remodeling-related molecular markers, such as interleukin (IL)-13, IL-17, matrix metalloproteinase 9, N-cadherin, alpha-smooth muscle actin (alpha-SMA), S100A4, Twist, epithelial goblet cell metaplasia, and collagen deposition in bronchoalveolar lavage fluid (BAL fluid) and lung tissues. Moreover, remodeling-related eosinophil accumulation in the BAL fluid and infiltration into the lung tissue were improved by AUDA. Finally, AUDA alleviated AHR, which is a functional indicator of airway remodeling. The effect of AUDA on airway remodeling was related to the downregulation of extracellular-regulated protein kinases (Erk1/2), c-Jun N-terminal kinases (JNK) and signal transducer and activator of transcription 3 (STAT3). To our knowledge, this is the first report to demonstrate that inhibition of sEH exerts significant protective effects on airway remodeling in asthma.

PubMedSearch : Jiang_2020_Eur.J.Pharmacol_868_172874
PubMedID: 31866410

Related information

Citations formats

Jiang JX, Guan Y, Shen HJ, Jia YL, Shen J, Zhang LH, Liu Q, Zhu YL, Xie QM (2020)
Inhibition of soluble epoxide hydrolase attenuates airway remodeling in a chronic asthma model
European Journal of Pharmacology 868 :172874

Jiang JX, Guan Y, Shen HJ, Jia YL, Shen J, Zhang LH, Liu Q, Zhu YL, Xie QM (2020)
European Journal of Pharmacology 868 :172874